HIYA

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke HIYA wurde als Wortmarke am 11.03.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 06. Mai 2022

Markenform Wortmarke
Aktenzeichen 1534644
Länder Europäische Gemeinschaft Großbritannien Vereinigte Staaten von Amerika (USA)
Basismarke CA Nr. 1984923, 12. September 2019
Anmeldedatum 11. März 2020
Ablaufdatum 11. März 2030

Markeninhaber

40 Larch Street,
Suite #201, Ontario
CA

Markenvertreter

275 Slater Street, 14th floor, Ontario CA

Waren und Dienstleistungen

05 Cannabidiol [cbd] oil for medical purposes; cannabis oil for the treatment of cancer; aerosol dispensers for medical use sold filled with a cannabidiol [cbd] preparations; inhaled pharmaceutical preparations for treating respiratory diseases and disorders; tetrahydrocannabinol [thc] oil for medical purposes; medicinal cannabis for temporary relief of seizures; medicinal cannabis for the relief of nausea caused by chemotherapy; medicinal cannabis for the relief of nerve pain; medicinal cannabis for the treatment of muscle spasms caused by multiple sclerosis; medicinal marijuana for temporary relief of seizures; medicinal marijuana for the relief of nausea caused by chemotherapy; medicinal marijuana for the relief of nerve pain; medicinal marijuana for the treatment of muscle spasms caused by multiple sclerosis; sprays for the relief of pain; medicinal, herbal, botanical, vitamin and nutritional preparations and supplements for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, muscle spasms, to enhance mood and to improve general state of well-being; oral vaporizers and inhalers sold filled medicinal, herbal, botanical, vitamin and nutritional preparations and supplements for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, muscle spasms, to enhance mood and to improve general state of well-being; oral vaporizer sold filled with cannabidiol [cbd] in the form of buccal sprays for the temporary relief of seizures, for the relief of nausea caused by chemotherapy, for the relief of nerve pain, for the treatment of muscle spasms caused by multiple sclerosis and for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, anxiety, fatigue, general pain, muscle tension, muscle spasms, to enhance mood and to improve general state of well-being; oral vaporizer sold filled with cannabidiol for medical purposes; tetrahydrocannabinol [thc] in the form of buccal sprays for the temporary relief of seizures, for the relief of nausea caused by chemotherapy, for the relief of nerve pain, for the treatment of muscle spasms caused by multiple sclerosis and for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, anxiety, fatigue, general pain, muscle tension, muscle spasms, to enhance mood and to improve general state of well-being; inhaler sold filled with cannabidiol for medical purposes; pharmaceutical preparations comprising cannabidiol [cbd] delivered through vaporizers, nebulizers and inhalers for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, muscle spasms, to enhance mood and to improve general state of well-being; medicinal, herbal, botanical and nutritional preparations and supplements containing cannabidiol [cbd] for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, muscle spasms, to enhance mood and to improve general state of well-being; medicinal, herbal, botanical and nutritional preparations and supplements containing tetrahydrocannabinol [thc] for the treatment of glaucoma, arthritis, chronic back pain, burns, ulcers, warts, moles, migraine headaches, asthma, insomnia, anxiety, depression, stress, loss of appetite, fatigue, general pain, muscle tension, muscle spasms, to enhance mood and to improve general state of well-being
10 Vaporizers for medical purposes; inhalers for therapeutic use; medical apparatus for facilitating the inhalation of pharmaceutical preparations
34 Oral vaporizers for smokers; vape pens; electronic cigarettes; smokeless cigarette vaporizer pipes; vaporizers for electronic cigarettes; oral vaporizers and electronic cigarettes for inhaling cannabis, marijuana and their derivatives; oral vaporizers and inhalers sold filed with cannabidiol [cbd]; oral vaporizers and inhalers sold filed with tetrahydrocannabinol [thc]; oil for electronic cigarettes; cannabidiol [cbd] oil for oral vaporizers for smoking; cannabis oil for electronic cigarettes; cannabis oil for oral vaporizers for smoking; tetrahydrocannabinol [thc] oil for electronic cigarettes; tetrahydrocannabinol [thc] oil for oral vaporizers for smoking; cannabidiol [cbd] oil for smoking; tetrahydrocannabinol [thc] oil for smoking; essential oils for use in oral vaporizers and electronic cigarettes; herbal extracts for use in oral vaporizers and electronic cigarettes; cartridges sold filled with cannabidiol [cbd] for electronic cigarettes and oral vaporizers; cartridges sold filled with tetrahydrocannabinol [thc] for electronic cigarettes and oral vaporizers
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
03. Mai 2022 2022/18 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
29. Oktober 2020 2020/44 Gaz EM Ablehnung
15. Oktober 2020 2020/42 Gaz US Ablehnung
04. September 2020 2020/36 Gaz GB Ablehnung
11. März 2020 2020/22 Gaz CA Eintragung

ID: 141534644